Value and limitations of a highly sensitive immunoradiometric assay for thyrotropin in the study of thyrotroph function
Using a highly sensitive and specific immunoradiometric assay for thyrotropin, we studied thyrotroph function in 232 new patients referred to a thyroid clinic and in 13 patients after treatment for hyperthyroidism. Significant thyrotroph responsiveness to thyroliberin (thyrotropin-releasing hormone, TRH) was found in all patients with values for basal thyrotropin greater than 0.1 milli-int unit/L. In no overtly hyperthyroid patient was any increment in thyrotropin recorded at 20 min after thyroliberin administration. In seven patients, four subclinically hyperthyroid and three who had received treatment, increments in thyrotropin from undetectable basal values were recorded, consistent with incomplete thyrotroph suppression. By use of assays with even higher sensitivity, one may be able to distinguish these patients from overtly hyperthyroid patients.
- Research Organization:
- Univ. Department of Medicine, Edinburgh, England
- OSTI ID:
- 6708567
- Journal Information:
- Clin. Chem. (Winston-Salem, N.C.); (United States), Journal Name: Clin. Chem. (Winston-Salem, N.C.); (United States); ISSN CLCHA
- Country of Publication:
- United States
- Language:
- English
Similar Records
New monoclonal-antibody two-site solid-phase immunoradiometric assay for human thyrotropin evaluated
Thyroid hormones regulate levels of thyrotropin-releasing-hormone mRNA in the paraventricular nucleus